We report our experience with high-dose chemotherapy (HDC) and autologous SCT (ASCT) in 66 patients with primary refractory Hodgkin's lymphoma (PR-HL) who received salvage chemotherapy followed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback